UPDATE 1-Merck says hepatitis C drugs to lose breakthrough status
February 04, 2015 at 08:22 AM EST
Feb 4 (Reuters) - Merck & Co on Wednesday said the U.S. Food and Drug Administration intends to rescind its "breakthrough therapy" designation for its experimental combination treatment for hepatitis C because of other recently approved treatments.
